The Europe hyperspectral imaging systems market size is expected to reach USD 7.56 billion by 2030, registering a CAGR of 10.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. The HSI technology is highly useful in detecting a broad spectrum of light rather than simply assigning the primary colors (red, green, and blue) to each pixel. It is used in a variety of applications, including the chemical, pharmaceutical, medical diagnostic, food, agricultural, aerospace, and defense industries. The growing use of HSI in these applications is expected to boost industry growth. Furthermore, the technological advancements in instrumentation and data analysis of HSI are expected to contribute to market growth.
The industry is expected to develop in the coming years as a result of rapid industrialization and the demand for high bandwidth communication. In addition, to obtain a competitive edge, leading competitors are shifting to product upgrades, regional expansions, portfolio diversifications, and mergers & acquisitions. For instance, in May 2022, Specim, a leading HSI instruments & systems manufacturer, in partnership with Grupo Álava, strengthened its presence in Spain and Portugal. In addition, industry expansion is predicted to be fueled by the increased R&D and growth prospects in Europe as well as efforts to uphold international product quality standards.
Growing chemical, pharmaceutical, food, aerospace, medical diagnostics, and defense industries coupled with increasing awareness about precision diagnosis across the region are also expected to contribute to the industry growth. Furthermore, there has been growing adoption of hyperspectral technologies in hospitals for the identification and diagnosis of solid tumors and imaging guidance tools during the joining of tissues after tumor removal, especially in gastric cancer. This is expected to boost the demand for HSI technology. Cancer has become one of the leading causes of death in Europe, thus augmenting the adoption of HSI. For instance, according to the International Agency for Research on Cancer, Europe accounted for about 4,398,443 new cancer cases and 1,955,231 deaths in 2020.
Request a free sample copy or view report summary: Europe Hyperspectral Imaging Systems Market Report
The camera segment dominated the market in 2024 and is also expected to grow at the fastest CAGR of 10.5% over the forecast period.
The snapshot technology segment held the largest market share of 51.5% in 2024 and is also expected to grow at the fastest rate over the forecast period.
The military surveillance segment held the largest market share of 32% in 2024, owing to the increasing demand for advanced imaging technologies in defense and security applications.
Grand View Research has segmented Europe hyperspectral imaging systems market report based on product, technology, application, and country:
Europe Hyperspectral Imaging Systems Product Outlook (Revenue, USD Million, 2018 - 2030)
Camera
Accessories
Europe Hyperspectral Imaging Systems Technology Outlook (Revenue, USD Million, 2018 - 2030)
Snapshot
Push Broom
Others
Europe Hyperspectral Imaging Systems Application Outlook (Revenue, USD Million, 2018 - 2030)
Military Surveillance
Remote Sensing
Medical Diagnostics
Machine Vision & Optical Sorting
Others
Europe Hyperspectral Imaging Systems Country Outlook (Revenue, USD Million, 2018 - 2030)
Germany
U.K.
France
Italy
Spain
Denmark
Sweden
Norway
List of Key Players in the Europe Hyperspectral Imaging Systems Market
Imec
XIMEA GmbH
Resonon, Inc.
Headwall Photonics, Inc.
Telops, Inc.
Corning, Inc.
Norsk Elektro Optikk AS
Cubert GmbH
EVK DI Kerschhaggl GmbH
Inno-spec GmbH
SPECIM Spectral Imaging Ltd.
Diaspective Vision GmbH
"The quality of research they have done for us has been excellent..."